Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.

Patel SH, Diaz IC, Zhang Z, Zhao W, Dietrich WD, Bramlett HM, Szczesna-Cordary D, Raval AP

Open source

DOI
10.1161/strokeaha.125.053168
Published
2026 Jan
Container
Stroke
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/strokeaha.125.053168,
  title = {Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.},
  author = {Patel SH and Diaz IC and Zhang Z and Zhao W and Dietrich WD and Bramlett HM and Szczesna-Cordary D and Raval AP},
  year = {2026},
  journal = {Stroke},
  doi = {10.1161/strokeaha.125.053168},
  url = {https://doi.org/10.1161/strokeaha.125.053168}
}

RIS

TY  - JOUR
TI  - Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.
AU  - Patel SH
AU  - Diaz IC
AU  - Zhang Z
AU  - Zhao W
AU  - Dietrich WD
AU  - Bramlett HM
AU  - Szczesna-Cordary D
AU  - Raval AP
PY  - 2026
JO  - Stroke
DO  - 10.1161/strokeaha.125.053168
UR  - https://doi.org/10.1161/strokeaha.125.053168
ER  - 

APA

SH, P., IC, D., Z, Z., W, Z., WD, D., HM, B., D, S., & AP, R. (2026). Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.. Stroke. https://doi.org/10.1161/strokeaha.125.053168

Source records